Skip to main content
Premium Trial:

Request an Annual Quote

Investment Firm's Increased Stake in ABI Topped Most Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb Daily News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, May 2.
1. Investment Firm Ups Stake in ABI; Encourages Board to Seek 'Strategic Alternatives' (from April 28)
2. US House Passes Genetic Discrimination Bill (from May 1)
3. Global Consortium Forms to Advance Cancer Genomics (from April 29)
4. Genetic Rearrangements Found in Cancer Cell Lines Using Massively Parallel Paired-End Sequencing (from April 28)


5. Collaborators Map Structural Variation in Human Genome (from April 30)
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.